Should what we know about neurobehavioral development, complex congenital heart disease, and brain maturation affect

James A DiNardo1

  • 1Children's Hospital Boston, Department of Anesthesiology, Boston, MA 02115, USA. james.dinardo@childrens.harvard.edu

Paediatric Anaesthesia
|November 25, 2010
PubMed

Insights

Infants with complex congenital heart disease often experience adverse neurobehavioral outcomes after cardiac surgery. Their developing brains are uniquely vulnerable to injury, and delaying surgery for maturation may improve outcomes.

Area of Science:

  • Neonatal neurology
  • Pediatric cardiology
  • Neurodevelopmental outcomes

Background:

  • Adverse neurobehavioral outcomes are common after neonatal and infant cardiac surgery, despite improved perioperative care.
  • Complex congenital heart disease is linked to abnormal fetal brain development and delayed maturation.
  • Neonates with complex congenital heart disease show significant cerebral ischemic/hypoxic injury before and after surgery.

Purpose of the Study:

  • To investigate the vulnerability of the neonatal brain to perioperative injury in complex congenital heart disease.
  • To explore the potential benefits of delaying surgical correction for improved brain maturation and neurobehavioral outcomes.

Main Methods:

  • Review of existing literature on neonatal brain development and injury in congenital heart disease.
  • Analysis of neurobehavioral outcomes in relation to perioperative care and surgical timing.
  • Assessment of cerebral ischemic/hypoxic injury markers in affected neonates.

Main Results:

  • The neonatal brain in complex congenital heart disease cases exhibits unique vulnerability to perioperative ischemic/hypoxic injury.
  • Cerebral injury is detectable both preoperatively and postoperatively in these infants.
  • Current data suggests a high incidence of neurobehavioral deficits.

Conclusions:

  • Neonatal and infant brains with complex congenital heart disease are highly susceptible to perioperative injury.
  • Further research is needed to determine if delaying surgical intervention to allow for brain maturation can mitigate these adverse neurobehavioral outcomes.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...